
Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
A major study of 30,000 people has found that three antidepressants work better than fluoxetine (Prozac) at helping people with depression recover and stay well over time.
The research, published in The Lancet Psychiatry, analyzed 115 previous clinical trials involving more than 30,000 people to determine how well 20 antidepressants eased depression symptoms and helped prevent them from returning over time. The study used fluoxetine, widely known by the brand name Prozac, as the main comparison drug.
Superior medications identified
Researchers found that escitalopram (Lexapro), duloxetine (Cymbalta), and agomelatine performed better over the long term than fluoxetine. Eli Lilly, which discontinued manufacturing Prozac in 2024, noted that fluoxetine remains available in many FDA-approved generic medicines.
Treatment considerations
Among the selective serotonin reuptake inhibitors (SSRIs) included in the study, escitalopram appeared to work best at helping patients stay well over time. However, researchers stressed that the findings cannot predict which antidepressant will work best for a specific patient.
Broader treatment approach
Dr. Carole Lieberman, a psychiatrist not involved in the study, urged caution when interpreting the findings, noting that agomelatine is not approved in the U.S. She emphasized that the best way to treat depression isn't always with antidepressants alone.
Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy. The researchers acknowledged limitations to their study, which combined results from previous trials rather than enrolling new patients.
People with questions about their antidepressants should speak with their doctor before making any medication changes. Fox News Digital reached out to the researchers and additional drug manufacturers for comment.